相关实验视频
Updated: Jul 5, 2025

05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
12.2K
具有双尾核硫胺的新型碳酸无水酶抑制剂对玻璃眼治疗显示出强大而持久的效果
Andrea Angeli1, Irene Chelli1, Laura Lucarini2
1NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Florence, Italy.
Journal of medicinal chemistry
|January 24, 2024
概括
研究人员开发了新型的碳酸酶抑制剂来治疗眼. 化合物26a在子中显著和持续地降低了眼内压力 (IOP),表现优于现有的玻璃眼瘤药物.
科学领域:
- 药用化学 医学化学
- 眼科医生 眼科 眼科
- 生物化学 生物化学
背景情况:
- 玻璃眼是全球不可逆转失明的主要原因.
- 眼内压升高 (IOP) 是青光眼的关键风险因素.
- 碳酸酶 (CA) 酶与玻璃眼病原发生有关.
研究的目的:
- 设计和合成新的双尾碳酸胺酶抑制剂.
- 评估这些抑制剂与眼相关的CA异型 (hCA II,hCA IV,hCA XII) 相比.
- 评估有希望的化合物在降低IOP的体内疗效.
主要方法:
- 合成了39种新型双尾碳酸胺酶抑制剂.
- 在体外抑制对hCA II,hCA IV和hCA XII的测定.
- 用X射线结晶学来确定抑制剂-酶复合体.
- 在子眼睛高血压模型中的体内内压力降低研究.
主要成果:
- 成功设计和合成39种新型CA抑制剂.
- 确定关键化合物与CA II结合的X射线晶体结构和hCA XII模仿的关键化合物.
- 化合物26a在子中表现出强大且持续的内血压降低作用.
- 与多佐胺和比马托普罗斯特相比,化合物26a显示出更高的疗效.
结论:
- 双尾方法产生了强大的碳酸胺酶抑制剂.
- 化合物26a显示显著的希望作为一种新的治疗药物治疗眼.
- 进一步开发26a化合物可能会导致有效的抗光眼瘤药物.
更多相关视频
相关概念视频
Open Angle Glaucoma: Treatment
452
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
452
Angle Closure Glaucoma: Treatment
500
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
500
Glaucoma: Overview
573
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
573
Antihypertensive Drugs: Thiazide-Class Diuretics
639
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
639
Antihypertensive Drugs: Potassium-Sparing Diuretics
560
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
560
Antihypertensive Drugs: Direct Renin Inhibitors
630
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
630

